Request Call-back

Leave your name, number and a brief message and one of our staff will give you a call

Humira (Adalimumab) (2x1ml Pens) Autoinjector 40mg/0.8ml

Brand Choice

Product from Canada

Humira (Adalimumab) (2x1ml Pens) Autoinjector

Manufactured by: abbvie

From $1099.99 USD per Pen(s)

CAN NOT BE SPLIT Must be taken in existing form.

PRESCRIPTION REQUIRED

This item is temperature sensitive and cannot be shipped currently. However IN-STORE pickup is available.

Generic Choice

Product from Canada

No Generic Alternative Available

No generic alternative is available for this drug.

What is a Generic in Canada? Health Canada (the Canadian regulatory board) evaluates every Canadian generic for their safety, effectiveness, and quality. Every generic used in Canada has the same medical ingredients as their brand name counterpart and is considered bioequivalent to the brand name medication. The quality standards for brand name drugs and generic drugs are the same. All of the ingredients, facilities, and manufacturing processes must meet Canadian federal guidelines for Good Manufacturing Practices. In addition, Canadian generic manufacturers must perform 'comparative bioavailability' studies to demonstrate that their generic products deliver the same amount of medicinal ingredient at the same rate as the brand name medication. Nearly 45% of all prescriptions filled in Canada use generic medication and some hospitals exclusively use generic drugs. For more information, please visit  http://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/med-gen-eng.php

NOTE: Not the same as 40mg/0.4mL (citrate free).  40/0.8mL (contain citrate) can cause a burning sensation during injection.

HUMIRA is a medicine called a Tumor Necrosis Factor (TNF) blocker. HUMIRA is used:

  • To reduce the signs and symptoms of:
    • moderate to severe rheumatoid arthritis (RA) in adults. HUMIRA can be used alone, with methotrexate, or with certain other medicines.
    • moderate to severe polyarticular juvenile idiopathic arthritis (JIA) in children 2 years and older. HUMIRA can be used alone, with methotrexate, or with certain other medicines.
    • psoriatic arthritis (PsA) in adults. HUMIRA can be used alone or with certain other medicines.
    • ankylosing spondylitis (AS) in adults.
    • moderate to severe Crohn’s disease (CD) in adults when other treatments have not worked well enough.
    • moderate to severe Crohn’s disease (CD) in children 6 years and older when other treatments have not worked well enough.
    • moderate to severe hidradenitis suppurativa (HS) in people 12 years and older.
  • In adults, to help get moderate to severe ulcerative colitis (UC) under control (induce remission) and keep it under control (sustain remission) when certain other medicines have not worked well enough. It is not known if HUMIRA is effective in people who stopped responding to or could not tolerate TNF-blocker medicines.
  • To treat moderate to severe chronic (lasting a long time) plaque psoriasis (Ps) in adults who have the condition in many areas of their body and who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet light alone or with pills).
  • To treat non-infectious intermediate, posterior, and panuveitis in adults and children 2 years of age and older.
    Source: https://www.rxlist.com/humira-drug.htm